BX Swiss TOP 30 CHF
1.185,32
PKT
-2,74
PKT
-0,23
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 16.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.04.24 | Zurich Insurance Hold | Deutsche Bank AG | |
| 15.04.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 15.04.24 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 12.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 12.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 12.04.24 | Givaudan Hold | Deutsche Bank AG | |
| 12.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 11.04.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.04.24 | Givaudan Sell | UBS AG | |
| 11.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 11.04.24 | Givaudan Reduce | Baader Bank | |
| 11.04.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.24 | UBS Outperform | RBC Capital Markets | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 09.04.24 | Roche Neutral | UBS AG | |
| 09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Roche Equal Weight | Barclays Capital | |
| 08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.04.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
| 04.04.24 | UBS Outperform | RBC Capital Markets | |
| 03.04.24 | Swiss Re Sell | UBS AG | |
| 03.04.24 | Givaudan Sell | UBS AG | |
| 03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Givaudan Underweight | Barclays Capital | |
| 02.04.24 | Richemont Overweight | Barclays Capital | |
| 02.04.24 | Richemont Buy | UBS AG | |
| 02.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG |